[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"norm-eurlex-reg_2012_270-erwgr-11-de":3},{"law":4,"norm_id":14,"norm_key":15,"slug":16,"title":17,"chapter":18,"content":19,"enriched_content":20,"hierarchy":21,"neighbors_before":22,"neighbors_after":32,"citing_decisions":42,"is_thin":43},{"abbreviation":5,"title":6,"source_type":7,"jurisdiction":8,"document_kind":9,"language":10,"attribution":11,"version_date":12,"source_url":13},"reg_2012_270","zur Änderung der Anhänge II und III der Verordnung (EG) Nr. 396\u002F2005 des Europäischen Parlaments und des Rates hinsichtlich der Rückstandshöchstgehalte für Amidosulfuron, Azoxystrobin, Bentazon, Bixafen, Cyproconazol, Fluopyram, Imazapic, Malathion, Propiconazol und Spinosad in oder auf bestimmten Erzeugnissen","eurlex","eu","regulation","de","© Europäische Union, https:\u002F\u002Feur-lex.europa.eu","2025-07-12","https:\u002F\u002Feur-lex.europa.eu\u002Flegal-content\u002FDE\u002FALL\u002F?uri=CELEX:32012R0270",7075304,"ErwGr. 11","erwgr-11",null,"Erwägungsgründe","Die Verordnung (EG) Nr. 396\u002F2005 sollte dementsprechend geändert werden.","REG_2012_270 - Erwägungsgründe - ErwGr. 11\n\nDie Verordnung (EG) Nr. 396\u002F2005 sollte dementsprechend geändert werden.",{},[23,26,29],{"norm_key":24,"title":17,"slug":25},"ErwGr. 10","erwgr-10",{"norm_key":27,"title":17,"slug":28},"ErwGr. 9","erwgr-9",{"norm_key":30,"title":17,"slug":31},"ErwGr. 8","erwgr-8",[33,36,39],{"norm_key":34,"title":17,"slug":35},"ErwGr. 12","erwgr-12",{"norm_key":37,"title":17,"slug":38},"Art. 1","art-1",{"norm_key":40,"title":17,"slug":41},"Art. 2","art-2",[],true]